Literature DB >> 28516883

Sarcoidosis and tocilizumab: is there a link?

Lindsay Bustamente1, Matthieu Buscot2, Charles-Hugo Marquette3, Christian Roux4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28516883

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  4 in total

1.  Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents.

Authors:  Michelle Sharp; Seamas C Donnelly; David R Moller
Journal:  Respir Med X       Date:  2019-02-21

2.  New-onset cutaneous sarcoidosis under tocilizumab treatment for giant cell arteritis: a quasi-paradoxical adverse drug reaction. Case report and literature review.

Authors:  Rosaria Del Giorno; Alfonso Iodice; Cristina Mangas; Luca Gabutti
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-04-12       Impact factor: 5.346

Review 3.  Refractory Sarcoidosis: A Review.

Authors:  Thomas El Jammal; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Dominique Valeyre; Pascal Sève
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

Review 4.  Emerging Molecular Targets for the Treatment of Refractory Sarcoidosis.

Authors:  Gonçalo Boleto; Matheus Vieira; Anne Claire Desbois; David Saadoun; Patrice Cacoub
Journal:  Front Med (Lausanne)       Date:  2020-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.